Aspira Women’s Health (AWH) has released an update to notify the public and investors about a material modification to rights of security holders.
The Company has amended the Common Stock Purchase Warrants issued to certain institutional and accredited investors on August 24, 2022, by altering the exercise price from $0.88 to $4.00 per share post a 1-15 reverse stock split and extending the termination date from August 25, 2027, to January 26, 2029. This amendment affects the original issuance of warrants to purchase 5,499,999 common stock shares, which adjusted to 366,664 shares following the reverse split.
For further insights into AWH stock, check out TipRanks’ Stock Analysis page.
